Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nancy Lackhyun Cho, M.D.

Co-Author

This page shows the publications co-authored by Nancy Cho and Erik Alexander.
Connection Strength

2.322
  1. Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines. Ann Surg Oncol. 2021 Jan; 28(1):484-491.
    View in: PubMed
    Score: 0.220
  2. A Cohort Analysis of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive Thyroid Nodules. J Clin Endocrinol Metab. 2019 11 01; 104(11):5665-5672.
    View in: PubMed
    Score: 0.211
  3. The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer. J Endocr Soc. 2019 Apr 01; 3(4):791-800.
    View in: PubMed
    Score: 0.201
  4. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery. Ann Surg Oncol. 2019 Jan; 26(1):93-97.
    View in: PubMed
    Score: 0.196
  5. Differential Growth Rates of Benign vs. Malignant Thyroid Nodules. J Clin Endocrinol Metab. 2017 12 01; 102(12):4642-4647.
    View in: PubMed
    Score: 0.184
  6. Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer. J Am Coll Surg. 2017 Jun; 224(6):1021-1027.
    View in: PubMed
    Score: 0.173
  7. Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 12; 101(12):4938-4944.
    View in: PubMed
    Score: 0.170
  8. Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis. Thyroid. 2016 Feb; 26(2):256-61.
    View in: PubMed
    Score: 0.161
  9. The variable phenotype and low-risk nature of RAS-positive thyroid nodules. BMC Med. 2015 Aug 07; 13:184.
    View in: PubMed
    Score: 0.157
  10. False negative cytology in large thyroid nodules. Ann Surg Oncol. 2015 Jan; 22(1):152-7.
    View in: PubMed
    Score: 0.146
  11. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013 Feb; 98(2):564-70.
    View in: PubMed
    Score: 0.131
  12. Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients. Clin Cancer Res. 2021 08 01; 27(15):4256-4264.
    View in: PubMed
    Score: 0.059
  13. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid. 2021 06; 31(6):933-940.
    View in: PubMed
    Score: 0.057
  14. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component. Endocr Pathol. 2020 Sep; 31(3):283-290.
    View in: PubMed
    Score: 0.056
  15. A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma. Histopathology. 2020 Apr; 76(5):707-713.
    View in: PubMed
    Score: 0.054
  16. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid. 2019 09; 29(9):1255-1261.
    View in: PubMed
    Score: 0.052
  17. Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients =70 Years Old. Thyroid. 2018 04; 28(4):465-471.
    View in: PubMed
    Score: 0.047
  18. Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule. Ann Surg Oncol. 2018 May; 25(5):1410-1417.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.